Get the Stockscreener App
3.84
0.26%
-0.01
Basel Medical Group Ltd Stock (BMGL) Forecast
The Basel Medical Group Ltd (BMGL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.32, representing a +194.79% increase from the current price of $3.84. The highest analyst price target is $22.29, and the lowest is $0.3509.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BMGL Price Target
Average 36.98
(+863.01% Upside)
Is Basel Medical Group Ltd (BMGL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 47.48 | Neutral |
| STOCH(9,6) | 77.70 | Neutral |
| STOCHRSI(14) | 98.81 | Sell |
| MACD(12,26) | -0.2748 | Buy |
| ADX(14) | 7.7931 | Neutral |
| William %R | -26.44 | Neutral |
| CCI(14) | 38.62 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.566
Buy
|
3.69
Buy
|
| MA20 |
3.6675
Buy
|
3.8324
Buy
|
| MA50 |
4.5936
Sell
|
4.5294
Sell
|
| MA100 |
5.6979
Sell
|
5.5705
Sell
|
| MA200 |
6.7216
Sell
|
8.854
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, BMGL could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 7 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on BMGL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 47.48 indicates that BMGL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 77.7 indicates that BMGL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 98.81 indicates that BMGL is oversold. This suggests that BMGL price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 7.7931 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 38.62 indicates that BMGL is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term BMGL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Basel Medical Group Ltd financial reports and earnings history, Basel Medical Group Ltd (BMGL) stock could reach $20.84 by 2030, $291.17 by 2040 and $321.02 by 2050. See the projected annual prices until 2050 of the Basel Medical Group Ltd stock below:
- Basel Medical Group Ltd (BMGL) is expected to reach an average price of $120.08 in 2035, with a high prediction of $123.36 and a low estimate of $121.16. This indicates an $3,027% rise from the last recorded price of $3.84.
- Basel Medical Group Ltd (BMGL) stock is projected to chart a bullish course in 2040, with an average price target of $304.13, representing an $7,820% surge from its current level. The forecast ranges from a conservative $281.29 to a sky-high $291.17.
- Our analysts predict Basel Medical Group Ltd (BMGL) to jump 2,522% by 2045, soaring from $100.74 to an average price of $100.67, potentially reaching $115.99. While $100.74 is the low estimate, the potential upside is significant.
- Basel Medical Group Ltd (BMGL) stock is expected to climb by 2050, reaching an average of $301.70, a $7,757% jump from its current level. However, a wide range of estimates exists, with high and low targets of $321.02 and $302.48, respectively, highlighting the market's uncertainty.
Basel Medical Group Ltd Stock (BMGL) Year by Year Forecast
Basel Medical Group Ltd Stock (BMGL) Price Forecast for 2026
The predicted value for Basel Medical Group Ltd (BMGL) in 2026 is set at an average of $11.60. Estimates vary from a peak of $22.85 to a trough of $0.3509, indicating an +202.08% surge from the present price of $3.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $22.29 | $0.3509 | $22.29 | +480.44% |
| December, 2026 | $7.2489 | $0.409 | $22.85 | +88.77% |
Basel Medical Group Ltd Stock (BMGL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Basel Medical Group Ltd (BMGL) is $38.10, with a high forecast of $73.61 and a low forecast of $2.5913. This indicates an +892.19% increase from the last price of $3.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $23.63 | $4.9288 | $37.49 | +515.40% |
| February, 2027 | $9.1514 | $2.5913 | $73.61 | +138.32% |
| March, 2027 | $7.3116 | $9.3516 | $18.49 | +90.41% |
| April, 2027 | $9.4517 | $9.7516 | $8.6317 | +146.14% |
| May, 2027 | $8.3919 | $9.2319 | $8.2518 | +118.54% |
| June, 2027 | $11.07 | $10.07 | $8.632 | +188.33% |
| July, 2027 | $10.51 | $10.63 | $9.9521 | +173.75% |
| August, 2027 | $13.83 | $11.87 | $11.99 | +260.22% |
| September, 2027 | $18.79 | $17.39 | $17.56 | +389.39% |
| October, 2027 | $13.31 | $14.75 | $17.07 | +246.71% |
| November, 2027 | $13.51 | $13.47 | $13.06 | +251.80% |
| December, 2027 | $12.51 | $12.71 | $12.40 | +225.78% |
Basel Medical Group Ltd Stock (BMGL) Price Forecast for 2028
In 2028, Basel Medical Group Ltd (BMGL) is projected to reach an average price of $25.58, with a high projection of $50.74 and a low estimate of $0.424. This indicates an +566.23% rise from the last price of $3.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.313 | $9.8758 | $11.20 | +142.53% |
| February, 2028 | $7.1188 | $7.1188 | $8.9263 | +85.38% |
| March, 2028 | $6.1545 | $7.1772 | $6.696 | +60.27% |
| April, 2028 | $3.1234 | $4.5734 | $5.2333 | -18.66% |
| May, 2028 | $3.5786 | $3.9836 | $4.1435 | -6.81% |
| June, 2028 | $1.9537 | $2.4337 | $3.2536 | -49.12% |
| July, 2028 | $2.1939 | $2.0538 | $3.0262 | -42.87% |
| August, 2028 | $42.38 | $0.424 | $39.30 | +1,004% |
| September, 2028 | $34.28 | $40.92 | $40.30 | +792.63% |
| October, 2028 | $32.58 | $31.86 | $29.26 | +748.49% |
| November, 2028 | $52.58 | $35.58 | $30.87 | +1,269% |
| December, 2028 | $35.98 | $41.78 | $50.74 | +837.05% |
Basel Medical Group Ltd Stock (BMGL) Price Forecast for 2029
The 2029 price forecast for Basel Medical Group Ltd Stock (BMGL) is $38.76 on average, with a high prediction of $53.14 and a low estimate of $24.39. This represents an +909.49% increase from the previous price of $3.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $46.10 | $48.42 | $53.14 | +1,101% |
| February, 2029 | $45.34 | $45.42 | $43.42 | +1,081% |
| March, 2029 | $41.58 | $43.26 | $41.70 | +982.91% |
| April, 2029 | $39.82 | $40.90 | $40.46 | +937.08% |
| May, 2029 | $38.22 | $40.26 | $39.62 | +895.42% |
| June, 2029 | $40.34 | $39.26 | $39.26 | +950.64% |
| July, 2029 | $42.90 | $40.54 | $41.22 | +1,017% |
| August, 2029 | $36.76 | $39.43 | $42.24 | +857.22% |
| September, 2029 | $35.62 | $35.98 | $35.87 | +827.68% |
| October, 2029 | $29.87 | $32.19 | $33.67 | +677.92% |
| November, 2029 | $28.20 | $28.48 | $29.71 | +634.29% |
| December, 2029 | $21.76 | $24.39 | $27.19 | +466.62% |
Basel Medical Group Ltd Stock (BMGL) Price Forecast for 2030
Basel Medical Group Ltd Stock (BMGL) is expected to reach an average price of $47.62 in 2030, with a high forecast of $90.81 and a low forecast of $4.418. This signifies an +1,140% surge from the last price of $3.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $20.81 | $21.29 | $20.84 | +441.99% |
| February, 2030 | $16.88 | $17.60 | $18.55 | +339.50% |
| March, 2030 | $14.52 | $15.15 | $14.30 | +278.05% |
| April, 2030 | $10.67 | $11.42 | $13.06 | +177.80% |
| May, 2030 | $7.7777 | $8.4877 | $9.4675 | +102.54% |
| June, 2030 | $5.1179 | $6.3079 | $6.9278 | +33.28% |
| July, 2030 | $84.21 | $4.418 | $85.65 | +2,093% |
| August, 2030 | $75.45 | $75.45 | $78.75 | +1,865% |
| September, 2030 | $65.49 | $76.53 | $72.26 | +1,606% |
| October, 2030 | $70.41 | $80.97 | $90.81 | +1,734% |
| November, 2030 | $90.93 | $81.09 | $90.57 | +2,268% |
| December, 2030 | $79.41 | $80.85 | $89.79 | +1,968% |
0.00%
20.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):